Valuation
- Market cap
- 34,016,000
- Revenue TTM
- $0
- Net income TTM
- $-26,310,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 20,201
- Avg volume
- 325,494
- Day's range
- $3.86 – $3.95
- Shares out
- 8,700,000
- Stochastic %K
- 9%
- Beta
- 1.21
- Analysts
- Strong Buy
- Price target
- $40.00
Company profile
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator...
Show more
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the
clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 604 921 1810
- Website
- https://briacell.com
- Address
- Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
Latest news
No headlines yet.
Stocktwits
BHWinehouse
Oct 12, 11:29 AM
$BCTX We'll have a few possibilities for news coming soon. Earnings next week (maybe), SITC poster presentation in November and the data wait continues.
1 replies
AliceFireSteam
Oct 9, 8:52 PM
$BCTX very bullish, briacell mentioned in a merger as a "peer" comparator, trading at massive discount.
1 replies
Biotechlineup
Oct 9, 8:18 PM
$BCTX Patiently waiting for awareness of what we are holding. I have posted extensively on other boards and even got banned on the Moderna Reddit echo board of insanity. mRNA is being hyped as a cure for cancer yet the vaccine itself will fail commercially and is not the answer. Personalized Neo antigen mRNA is fine medical miracle except it’s logistically and financially impractical except for the few.
The future is off shelf like the Bctx platform. Faster , cheaper and just as effective if not more so. We are just waiting for the proof . If/ when we are sitting on a moon shot.
1 replies
BHWinehouse
Oct 9, 5:34 PM
$BCTX Only 15K shares traded so far, even BCTXL is over 35K.
0 replies
AliceFireSteam
Oct 9, 1:33 PM
$BCTX currently at 6666 shares for the lolz, adding more!
0 replies
BCTX20bMC
Oct 9, 6:52 AM
$BCTX if anyone has the time..read the
$IMMU comments. It was a super bumpy road to a 20b+ BO…including a massive sell downgrade when the data was released…then after all retail sold in a panic due to the sell downgrade…they ran it up 10x+. Long story short…HODL your shares for a BO…no matter what nonsense they throw at us. If you own shares you must be drinking the same cool aid I drink & have faith…don’t give your shares away when positive data arrives. HODL for GODL 🌋
1 replies
